KTTA

Pasithea Therapeutics Corp. (KTTA)

About Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.

Details

Daily high

$5.06

Daily low

$4.62

Price at open

$5.11

52 Week High

$17.40

52 Week Low

$3.61

Market cap

5.5M

Dividend yield

0.00%

Volume

11,880

Avg. volume

2.9M

P/E ratio

-.35

Pasithea Therapeutics Corp. News